Trials / Completed
CompletedNCT00855829
A Feasibility Study Designed to Assess the Efficacy of the ActiLady Device in Adult Female Subjects With Dysmenorrhea
A Single-Center, Randomized, Controlled, Double-Blind Feasibility Study Designed to Assess the Safety Performance of ActiLady Prototype in Adult Female Subjects With Dysmenorrhea.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
ActiLady refers is employing targeted pressure waves, with the goal of reducing the pain associated with menstruation (clinically known as dysmenorrhea).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Miniature Actilady device active | Devices: Targeted pressure waves are created by two kind of methods ActiLady). 1. The effect of the waves used will be examined by the use of a silicon tube or polyvinyl chloride (PVC) tube which is inserted into the vaginal cavity. The other end of the tube will be connected to an "off the shelf" pressure waves generator and controller. 2. Self manufactured device inserted into the vaginal cavity and creating subsound pressure waves. |
| DEVICE | Miniature Actilady device not active | Devices: Targeted pressure waves are created by two kind of methods ActiLady). The effect of the waves used will be examined by the use of a silicon tube or polyvinyl chloride (PVC) tube which is inserted into the vaginal cavity. The other end of the tube will be connected to an "off the shelf" pressure waves generator and controller. Self manufactured device inserted into the vaginal cavity and creating subsound pressure waves. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-05-01
- Completion
- 2013-10-01
- First posted
- 2009-03-04
- Last updated
- 2013-11-13
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT00855829. Inclusion in this directory is not an endorsement.